ARKG News and Press, ARK Genomic Revolution ETF From 12/12/19

By a 230-192 margin, the U.S. House of Representatives has passed legislation , championed by Speaker Nancy Pelosi, aimed at corralling spiralling drug costs. More news on: ProShares Trust - ProShares Ultra Nasdaq Biotechnology, Tekla World Healthcare Fund, ARK Genomic Revolution Multi-Se...

From the launch of the first exchange-traded fund back in 1993 with the SPDR S&P 500 ETF (NYSE: SPY ), the investment vehicle quickly gained popularity as a low-cost and highly liquid option for investors to gain passive exposure to broad market indexes. One of the themes this past decad...

The Institute for Clinical and Economic Review (ICER), a Boston-based nonpartisan nonprofit with no policy-making role, has emerged as a major influencer on pricing by drugmakers. More news on: Sanofi, Regeneron Pharmaceuticals, Inc., Amgen Inc., Healthcare stocks news, News on ETFs, ...

Gainers:  Natural Gas 3X Long ETN Velocityshares (NYSEARCA: UGAZ )  +30.2% . More news on: VelocityShares 3x Long Natural Gas ETN, ProShares Trust II - ProShares Ultra Bloomberg Natural Gas, Direxion Shares ETF Trust - Direxion Daily Pharmaceutical & Medical Bull 3X Shares,...

In a statement , the FDA says chronic shortages of certain medicines in the U.S. have not produced the expected responses from drugmakers that traditional economics predict, specifically, increasing prices to reflect a supply/demand imbalance aimed at achieving profitable production to sati...

A preliminary analysis from the nonpartisan Congressional Budget Office (CBO) found that House Speaker Nancy Pelosi's (D-CA 12th District) bill to lower drug prices would save Medicare $345B between 2023 and 2029 by allowing the Secretary of Health and Human Services to negotiated lower pr...

According to a new report from the nonprofit Institute for Clinical and Economic Review (ICER), AbbVie ( ABBV -0.6% ) and Roche ( OTCQX:RHHBY -1.6% ) were number one and two, respectively, in terms of the impact of their price increases on U.S. drug spending. More news on: AbbVie Inc...

Gainers:  Direxion S&P Biotech Bear 3X (NYSEARCA: LABD )  +25.9% . More news on: Direxion Daily S&P Biotech Bear 3x Shares ETF, Direxion Daily Natural Gas Related Bear 3X Shares ETF, VelocityShares 3x Inverse Natural Gas ETN, News on ETFs, Stocks on the move, Read m...

(Source - Pexels/Pixbay ) It is widely believed that the Healthcare sector is a safe sector in a recessionary environment because "people always need medical treatment." While that is historically true, it seems that many investors are underweighting the substantial risks in the sector. H...

In an interview with CNBC, Health Secretary Alex Azar revealed that the Trump administration is working on a plan that would allow the U.S. to import medicines from Canada, but offered no additional details as to how the plan would work. More news on: ProShares Trust - ProShares Ultra Na...